Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial

Desai, Akshay; Vaduganathan, Muthiah; Cleland, John; Claggett, Brian; Barkoudah, Ebrahim; Finn, Peter; McCausland, Finnian; YILMAZ, MEHMET; Lefkowitz, Martin; Shi, Victor; Pfeffer, Marc; McMurray, John; Solomon, Scott

doi:10.1161/circheartfailure.121.008597

Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial

Desai A. S., Vaduganathan M., Cleland J. G., Claggett B. L., Barkoudah E., Finn P., ...Daha Fazla

CIRCULATION-HEART FAILURE, cilt.14, sa.12, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 14 Sayı: 12
Basım Tarihi: 2021
Doi Numarası: 10.1161/circheartfailure.121.008597
Dergi Adı: CIRCULATION-HEART FAILURE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Anahtar Kelimeler: death, sudden, heart failure, neprilysin, valsartan
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

BACKGROUND: Patients with heart failure (HF) and preserved left ventricular ejection fraction comprise a heterogeneous group including some with mildly reduced EF. We hypothesized that mode of death differs by EF in ambulatory patients with HF and preserved left ventricular ejection fraction.